More patient studies will be needed to determine if dulaglutide drugs, like Trulicity, increase the risk of blood clots in their users
Insulin-like growth factor-1 (IGF-1), IL-6, TNF-, decorin, and osteonectin/secreted protein acidic and rich in cysteine (SPARC) levels were measured using commercially available enzyme immunoassay kits (total IGF-1, cat
Its not a matter of willpower
We now have the clinical data package to support global submissions for retatrutide as a potential treatment for obesity, knee osteoarthritis pain, and obstructive sleep apnea. Key takeaways: Retatrutide met primary endpoints in the TRIUMPH-2 and TRIUMPH-3 trials, delivering substantial weight loss at 80 weeks
PloS One (2011) 6:e19170
Your provider makes all final treatment decisions